The macrophage.

PubWeight™: 2.01‹?› | Rank: Top 2%

🔗 View Article (PMID 8526892)

Published in Bioessays on November 01, 1995

Authors

S Gordon1

Author Affiliations

1: University of Oxford, Sir William Dunn School of Pathology, UK.

Articles citing this

Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22

Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med (2007) 7.87

Adipose tissue remodeling and obesity. J Clin Invest (2011) 6.12

Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest (2010) 4.56

Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J Cell Biol (2003) 2.19

The renal mononuclear phagocytic system. J Am Soc Nephrol (2011) 1.84

Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur J Pharm Biopharm (2010) 1.67

Regulation of innate immune response by MAP kinase phosphatase-1. Cell Signal (2007) 1.65

Retracted TIF1beta functions as a coactivator for C/EBPbeta and is required for induced differentiation in the myelomonocytic cell line U937. Genes Dev (2001) 1.46

Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide. J Virol (2002) 1.43

The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans. Immunology (2001) 1.42

Human NM23/nucleoside diphosphate kinase regulates gene expression through DNA binding to nuclease-hypersensitive transcriptional elements. J Bioenerg Biomembr (2000) 1.39

The Rel subunit of NF-kappaB-like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations. EMBO J (1996) 1.34

Are human and mouse satellite cells really the same? J Histochem Cytochem (2010) 1.21

M-ficolin is expressed on monocytes and is a lectin binding to N-acetyl-D-glucosamine and mediates monocyte adhesion and phagocytosis of Escherichia coli. Immunology (2000) 1.18

CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells. Biochem J (2005) 1.16

Flt3+ macrophage precursors commit sequentially to osteoclasts, dendritic cells and microglia. BMC Immunol (2002) 1.14

Peripheral Blood Mononuclear Cells Enhance Cartilage Repair in in vivo Osteochondral Defect Model. PLoS One (2015) 1.14

Biosynthesis of human ficolin, an Escherichia coli-binding protein, by monocytes: comparison with the synthesis of two macrophage-specific proteins, C1q and the mannose receptor. Immunology (1996) 1.11

Ginseng, the 'Immunity Boost': The Effects of Panax ginseng on Immune System. J Ginseng Res (2012) 1.10

MAP kinase phosphatase-1, a critical negative regulator of the innate immune response. Int J Clin Exp Med (2009) 1.09

Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease. Life Sci (2011) 1.08

In vivo inhibition of c-MYC in myeloid cells impairs tumor-associated macrophage maturation and pro-tumoral activities. PLoS One (2012) 1.06

Inducible nitric-oxide synthase expression is regulated by mitogen-activated protein kinase phosphatase-1. J Biol Chem (2009) 1.02

Increased association of Trypanosoma cruzi with sialoadhesin positive mice macrophages. Parasitol Res (2005) 0.98

The potential role of sialoadhesin as a macrophage recognition molecule in health and disease. Glycoconj J (1997) 0.95

The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum. Immunology (2012) 0.92

Temporal changes in salivary glands of non-obese diabetic mice as a model for Sjögren's syndrome. Oral Dis (2011) 0.92

Heme oxygenase-1 as a therapeutic target in inflammatory disorders of the gastrointestinal tract. World J Gastroenterol (2010) 0.91

Generation of novel bone forming cells (monoosteophils) from the cathelicidin-derived peptide LL-37 treated monocytes. PLoS One (2010) 0.89

Differential utilization of Ras signaling pathways by macrophage colony-stimulating factor (CSF) and granulocyte-macrophage CSF receptors during macrophage differentiation. Mol Cell Biol (1998) 0.86

Identification, isolation, and characterization of daintain (allograft inflammatory factor 1), a macrophage polypeptide with effects on insulin secretion and abundantly present in the pancreas of prediabetic BB rats. Proc Natl Acad Sci U S A (1997) 0.86

Prenatal exposure to interleukin-6 results in hypertension and alterations in the renin-angiotensin system of the rat. J Physiol (2006) 0.85

Comparative Study of Injury Models for Studying Muscle Regeneration in Mice. PLoS One (2016) 0.83

Platelet-derived stromal cell-derived factor-1 is required for the transformation of circulating monocytes into multipotential cells. PLoS One (2013) 0.81

Macrophages in immunopathology of atherosclerosis: a target for diagnostics and therapy. Curr Pharm Des (2015) 0.79

Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice. J Nanobiotechnology (2013) 0.77

MAP Kinase Phosphatase-1 and Septic Shock. J Organ Dysfunct (2009) 0.76

Macrophages phagocytose nonopsonized silica particles using a unique microtubule-dependent pathway. Mol Biol Cell (2014) 0.76

Methotrexate and cyclosporine treatments modify the activities of dipeptidyl peptidase IV and prolyl oligopeptidase in murine macrophages. Clin Dev Immunol (2008) 0.75

Over-Expression of the Mycobacterial Trehalose-Phosphate Phosphatase OtsB2 Results in a Defect in Macrophage Phagocytosis Associated with Increased Mycobacterial-Macrophage Adhesion. Front Microbiol (2016) 0.75

Monocyte Activation in Immunopathology: Cellular Test for Development of Diagnostics and Therapy. J Immunol Res (2016) 0.75

Nanospheres encapsulating anti-leishmanial drugs for their specific macrophage targeting, reduced toxicity, and deliberate intracellular release. Vector Borne Zoonotic Dis (2012) 0.75